Actively Recruiting
Bio-markers of Not-celiac Wheat Sensitivity
Led by University of Palermo · Updated on 2025-06-22
100
Participants Needed
2
Research Sites
778 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the investigators' study is to evaluate biochemical, immunological and histological characteristics of patients affected with the so-called "gluten (or wheat) sensitivity" who suffers from irritable bowel syndrome (IBS)-like symptoms. As it is not known what component of the cereals causes the symptoms in so called "gluten-sensitive" patients, the investigators prefer to speak of "not-celiac wheat sensitivity" (NCWS). NCWS patients may be defined as ones, neither celiac or allergic to wheat, who develop symptoms following wheat consumption, that improved on wheat/gluten free diet (GFD). For our research, we will select adult patients, both genders, affected with suspected NCWS (i.e. with symptoms/signs which disappeared on GFD and worsen on a gluten containing diet, testing negative for celiac disease \[anti-tissue transglutaminase antibodies, anti-tTG, and anti-endomysium antibodies, EMA, and with biopsy Marsh 0-1\] and wheat allergy \[serum specific IgE for wheat\]). The patients will be recruited at the Department of Internal Medicine, 'Giovanni Paolo II' Hospital of Sciacca (Agrigento), and of Internal Medicine of the University of Palermo, from January 2012 to October 2013, for IBS-like symptoms. At the time of the recruitment, the patients will be on GFD by at least one month and must be asymptomatic. A more restricted elimination diet (with the exclusion of cow's milk, egg and other foods) could be prescribed in patients who are suspected to suffer from multiple food hypersensitivity. The patients will be randomized to undergo a double-blind placebo-controlled study, assuming wheat flour or placebo, administered daily for 15 days. Before and after the challenge, the investigators will evaluate gastrointestinal (Gastrointestinal Symptom Rating Scale, GSRS) and the investigators will collect blood and fecal sampling and biopsies from endoscopic evaluation (both esophagogastroduodenoscopy and rectoscopy, with multiple biopsies), for the identification of possible markers (serological, biochemical, immunological, histological features, expression of cytokines and other constitutive mucosal proteins from peripheral blood mononuclear cells, mucosal lymphocytes and fecal biomarkers) that may be of help to diagnose the condition of NCWS and to understand its pathogenesis.
CONDITIONS
Official Title
Bio-markers of Not-celiac Wheat Sensitivity
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 to 65 years with IBS-like symptoms that improve on a gluten-free diet and worsen on a gluten-containing diet
- Negative tests for celiac disease (anti-tTG and EMA negative, biopsy Marsh 0-1)
- Negative serum specific IgE for wheat (no wheat allergy)
You will not qualify if you...
- Diagnosis of celiac disease with positive anti-tTG and/or EMA and Marsh 2 or above histology
- Diagnosis of wheat allergy with positive serum specific IgE for wheat
- Type 1 diabetes
- Inflammatory bowel diseases such as Crohn's disease or ulcerative colitis
- Helicobacter pylori infection or other gastrointestinal infections
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Internal Medicine, "Giovanni Paolo II" Hospital
Sciacca, Agrigento, Italy
Actively Recruiting
2
Internal Medicine, University Hospital
Palermo, Palermo, Italy, 90100
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here